Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Author:
  • Pavel Elsakov
  • Lenka Foretova
  • Petr Goetz
  • Johannes W. B. de Groot
  • Winette T. A. van der Graaf
  • Gulnur Guler
  • Kay Huebner
  • Neva E. Haites
  • Ute Hamann
  • Judy Ho
  • Evgeny N. Imyanitov
  • Arvids Irmejs
  • Gunta Purkalne
  • Marianna Bitina
  • Andris Gardovskis
  • Janis Gardovskis
  • Youlia M. Kirova
  • Alain Fourquet
  • Jean-Yves Pierga
  • Dominique Stoppa-Lyonnet
  • Lidia Larizza
  • Cornelis J. M. Lips
  • Niklas Loman
  • Åke Borg
  • Pal Moller
  • Håkan Olsson
  • Jae-Gahb Park
  • Sinisa Radulovic
  • Mira Brankovic-Magic
  • Thangarajan Rajkumar
  • Evangelia Razis
  • Drakoulis Yannoukakos
  • Fernando Schmitt
  • Rita Schmutzler
  • Peter D. Simmonds
  • Diana Eccles
  • Jacob Smeltzer
  • Peter T. Silberstein
  • Henry Lynch
  • Walter Weber
  • Pax H. B. Willemse
  • Rolf H. Sijmons
  • Piotr J. Wysocki
  • Vladimir Zajac
  • Zheng Shu
Publishing year: 2007
Language: English
Pages: 119-143
Publication/Series: Hereditary Cancer in Clinical Practice
Volume: 5
Issue: 3
Document type: Journal article (comment)
Publisher: Termedia Publishing House

Keywords

  • Cancer and Oncology

Other

Published
  • ISSN: 1897-4287
Åke Borg
Åke Borg
E-mail: ake [dot] borg [at] med [dot] lu [dot] se

Principal investigator

Oncology and Pathology, MV

+46 46 275 25 52

MV 404 C21B2

90

Project manager

Familial Breast Cancer

90

Professor

Oncology and Pathology, MV

MV 404 C21C2

90